GB1554811A - Purifying hepatitis b surface antigen - Google Patents

Purifying hepatitis b surface antigen

Info

Publication number
GB1554811A
GB1554811A GB7657/77A GB765777A GB1554811A GB 1554811 A GB1554811 A GB 1554811A GB 7657/77 A GB7657/77 A GB 7657/77A GB 765777 A GB765777 A GB 765777A GB 1554811 A GB1554811 A GB 1554811A
Authority
GB
United Kingdom
Prior art keywords
hbsag
salt
hepatitis
density gradient
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7657/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GB729978A priority Critical patent/GB1554812A/en
Priority to GB7657/77A priority patent/GB1554811A/en
Priority to CA272,890A priority patent/CA1088426A/en
Priority to FR7706090A priority patent/FR2382238A1/fr
Priority to DE19772709581 priority patent/DE2709581A1/de
Priority to CH310877A priority patent/CH636269A5/de
Priority to JP2981477A priority patent/JPS53115812A/ja
Priority to FR7738613A priority patent/FR2412315A1/fr
Publication of GB1554811A publication Critical patent/GB1554811A/en
Priority to CA340,670A priority patent/CA1100039A/en
Priority to CA340,669A priority patent/CA1100038A/en
Priority to JP58010648A priority patent/JPS58180431A/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Centrifugal Separators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB7657/77A 1977-02-23 1977-02-23 Purifying hepatitis b surface antigen Expired GB1554811A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB729978A GB1554812A (en) 1977-02-23 1977-02-23 Purifying hepatitis b surface antigen
GB7657/77A GB1554811A (en) 1977-02-23 1977-02-23 Purifying hepatitis b surface antigen
CA272,890A CA1088426A (en) 1977-02-23 1977-03-01 Purification of hepatitis b antigen
FR7706090A FR2382238A1 (fr) 1977-02-23 1977-03-02 Procede de purification de l'antigene de l'hepatite b, et produits obtenus
DE19772709581 DE2709581A1 (de) 1977-02-23 1977-03-04 Hepatitis b-antigen
CH310877A CH636269A5 (en) 1977-02-23 1977-03-11 Process for the concentration of hepatitis B antigen and process for its purification
JP2981477A JPS53115812A (en) 1977-02-23 1977-03-19 Hepatisis b antigen
FR7738613A FR2412315A1 (fr) 1977-02-23 1977-12-21 Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu
CA340,670A CA1100039A (en) 1977-02-23 1979-11-27 Hepatitis b antigen
CA340,669A CA1100038A (en) 1977-02-23 1979-11-27 Hepatitis b antigen
JP58010648A JPS58180431A (ja) 1977-02-23 1983-01-27 肝炎ｂ抗原

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7657/77A GB1554811A (en) 1977-02-23 1977-02-23 Purifying hepatitis b surface antigen

Publications (1)

Publication Number Publication Date
GB1554811A true GB1554811A (en) 1979-10-31

Family

ID=9837320

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7657/77A Expired GB1554811A (en) 1977-02-23 1977-02-23 Purifying hepatitis b surface antigen

Country Status (6)

Country Link
JP (2) JPS53115812A (enrdf_load_stackoverflow)
CA (1) CA1088426A (enrdf_load_stackoverflow)
CH (1) CH636269A5 (enrdf_load_stackoverflow)
DE (1) DE2709581A1 (enrdf_load_stackoverflow)
FR (1) FR2382238A1 (enrdf_load_stackoverflow)
GB (1) GB1554811A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7711378A (nl) * 1976-11-02 1978-05-05 Merck & Co Inc Werkwijze voor het bereiden van preparaten die dane-deeltjes bevatten.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Also Published As

Publication number Publication date
JPS58180431A (ja) 1983-10-21
JPS53115812A (en) 1978-10-09
CH636269A5 (en) 1983-05-31
DE2709581A1 (de) 1978-09-07
DE2709581C2 (enrdf_load_stackoverflow) 1988-04-07
JPS6313969B2 (enrdf_load_stackoverflow) 1988-03-29
FR2382238A1 (fr) 1978-09-29
CA1088426A (en) 1980-10-28
FR2382238B1 (enrdf_load_stackoverflow) 1981-05-29

Similar Documents

Publication Publication Date Title
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
NO843749L (no) Fremgangsmaate ved fremstilling av immuninterferon
GB1554811A (en) Purifying hepatitis b surface antigen
ZA813479B (en) Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines
GB2065473B (en) Process for producing hepatitis b vaccine
DE3160343D1 (en) Process for producing 1,3-butadiene or 2-methyl-1,3-butadiene of high purity
GB2033376B (en) Process for recovery of resorcin
GB1538609A (en) Process for the preparation of organosiloxanes
ATE17720T1 (de) Verfahren zur herstellung von nicotinsaeureamide.
JPS5659716A (en) Separating method of gamma-globulin aggregate with membrane
SE7702612L (sv) Forfarande for framstellning av hogdispers kiseldioxid med forsterkt fortjockningsverken
SE7703617L (sv) Forfarande for framstellning av 2-klornikotinsyra
GB2017753B (en) Process for preparing monokaryons by dedikaryotizing dikaryotic strains of basidiomycetes
JPS51151397A (en) Method for preparing seasoning
PT65865A (en) Process for the preparation of substituted n-methylene derivatives of thienamycin
FR2412315A1 (fr) Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu
JPS51118825A (en) A process for preparing heat stable iga and igm
HUT47532A (en) Process for producing methyl-isocyanate
DK632187A (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
DE2963303D1 (en) 3-azabicyclo(3.1.0)hexane derivatives and process for their preparation
JPS528387A (en) Method of producing vacuum double bottle for thermos bottle
JPS521359A (en) Fixing process of lock bolt and its lock bolt
JPS6477893A (en) Far infrared radiation heater lamp
JPS5259021A (en) Method of producing superior ingot by electroslag remelting
JPS5250999A (en) Process for producin sodium esquicarbonate

Legal Events

Date Code Title Description
PS Patent sealed
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940223